Showing results (881-890 of 936) with videos related to
Sort By:
Pageof 94
Cell Metabolism|April 23, 2026
Cav3.1 is a neuronal leucine sensor that mediates satiety and weight loss in response to dietary proteinAnthony H Tsang, Nicholas Heeley, Constanza Alcaino, et al.The British Journal of Ophthalmology|May 19, 2021
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trialFelix Friedrich Reichel, Stylianos Michalakis, Barbara Wilhelm, et al.The British Journal of Ophthalmology|August 18, 2025
Safety and vision outcomes of subretinal gene supplementation therapy in PDE6A-associated retinitis pigmentosa: a non-randomised controlled trialFelix F Reichel, M Dominik Fischer, Katarina Stingl, et al.Asia-Pacific Journal of Clinical Oncology|April 14, 2015
Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancerBrigette B Ma, Frankie Mo, Joanna H Tong, et al.The Lancet. Oncology|December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine TrialCarolina Porras, Sabrina H Tsang, Rolando Herrero, et al.JCI Insight|April 10, 2020
Multiexon deletion alleles of ATF6 linked to achromatopsiaEun-Jin Lee, Wei-Chieh Jerry Chiang, Heike Kroeger, et al.Journal of the National Cancer Institute|May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine TrialShang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.Immunity|January 15, 2017
Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune ResponsesDavid Druzd, Olga Matveeva, Louise Ince, et al.The Journal of Infectious Diseases|September 15, 2022
Slow Waning of Antibodies Following BNT162b2 as a Third Dose in Adults Who Had Previously Received 2 Doses of Inactivated VaccineBenjamin J Cowling, Samuel M S Cheng, Mario Martín-Sánchez, et al.Pageof 94